Search results for CD38 antibody

Cyclic ADP Ribose Hydrolase (CD38) Antibody, Abbexa, abx102993

Polyclonal Antibody to Cyclic ADP Ribose Hydrolase (cADPRH).

Cyclic ADP Ribose Hydrolase (CD38) Antibody, Abbexa, abx010525

CD38 is a type II integral membrane glycoprotein which is present on early B and T cell lineages and activated B and T cells but is absent from most mature resting peripheral lymphocytes. CD38 is also found on thymocytes, pre-B cells, germinal center B cells, mitogen-activated T cells, monocytes and Ig-secreting plasma cells. CD38 acts as a NAD glycohydrolase in T lym- phocytes. On hematopoietic cells CD38 induces activation, proliferation, and differentiation of mature T and B cells and mediates apoptosis of myeloid and lymphoid progenitor cells. In addition to acting as a signaling receptor, CD38 is also an enzyme capable of producing several calcium-mobilizing metabo- lites, including cyclic adenosine diphosphate ribose (cADPR). CD38 also plays a role in maintaining survival of an invariant NK T (iNKT) cell subset that preferentially contributes to the maintenance of immunological tolerance.

Cyclic ADP Ribose Hydrolase (CD38) Antibody, Abbexa, abx021408

CD38 Antibody is a Mouse monoclonal antibody for human cds against CD38.

Anti-Human CD38 Antibody (38SB19) (HB691207), abinScience, HB691207

Anti-Human CD38 Antibody (SAA0013) (HB691107), abinScience, HB691107

Cyclic ADP Ribose Hydrolase (CD38) Antibody (PE), Abbexa, abx412644

Cyclic ADP Ribose Hydrolase (CD38) Antibody (PE) is a Mouse Monoclonal antibody against Cyclic ADP Ribose Hydrolase (CD38).

Cyclic ADP Ribose Hydrolase (CD38) Antibody (Biotin), Abbexa, abx139266

CD38 Antibody is a Mouse Monoclonal against CD38.

HRP Anti-CD38 antibody [SP149] (C-terminal), Abcam, AB306158

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE/Cy5® Anti-CD38 antibody [90], Abcam, AB25043

This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.

PE/Cy7® Anti-CD38 antibody [HIT2], Abcam, AB233569

This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.